Detalhe da pesquisa
1.
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
Gynecol Oncol
; 177: 60-71, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639904
2.
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Cancer Med
; 9(3): 1092-1103, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31808620